Skip to main content

GSK plc

GSK
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001131399

No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 989 institutions reported holding it in 13F filings for Q3 2026, worth $15.6B in total; no superinvestor holds it.

Other share classesGLAXF

Holders of 5% or more of GSK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of GSK plc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of GSK plc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on GSK plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GSK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20264:40 PM ETDodge & Cox13G/A4.30%173.3M shares–Below 5%Jun 30, 2026SEC
Nov 12, 20244:32 PM ETGSK plc13G/AOld format–––SEC
Feb 13, 2024Dodge & Cox13G/AOld format–––SEC
Feb 14, 2023Dodge & Cox13G/AOld format–––SEC
Feb 14, 2022Dodge & Cox13GOld format–New–SEC
Feb 7, 20224:40 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 29, 20219:54 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell GSK plc shares, newest first.

Form 144 notices for GSK
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 20, 202611:19 AM ETMartinez Maria EOfficer44.4K$2.31MAug 20, 2026CHARLES SCHWAB & COSEC